Reliable results even with low-quality RNA (RIN ≥ 2), expanding access and flexibility for complex samples.
Enhanced Data Quality
AI-enhanced, end-to-end transcriptome analysis eliminates manual bottlenecks and boosts interpretability.
Faster Turnaround
Accelerated insights in just 1–3 weeks, compared to the typical 4–8 week cycle.
Cost-Efficient Sequencing
Delivering AI-powered analysis at a fraction of the cost—up to 5x more affordable than traditional methods.